Angola vs Ukraine: The number of people with susceptibility test result for rifampicin
Angola
10,250
in 2021
Ukraine
9,237
in 2021
Angola rank
21st
Ukraine rank
23rd
The number of people with susceptibility test result for rifampicin over time
- Angola
- Ukraine
How they compare
Angola currently reports 10,250 against 9,237 in Ukraine, a difference of 1,013.
That makes Angola's figure about 1.1 times Ukraine's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Ukraine ahead.
Angola ranks 21st and Ukraine ranks 23rd of 155 countries.
Ukraine has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9,969 | 12,368 | 2,399 | Ukraine |
| 2020s | 5,672 | 9,015 | 3,342 | Ukraine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Angola or Ukraine?
- Angola, at 10,250 against 9,237 in Ukraine as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Angola and Ukraine?
- 1,013, with Angola ahead.
- How many years of comparable data are there for Angola and Ukraine?
- 5 years are reported by both, from 2017 to 2021.
- How do Angola and Ukraine rank globally for the number of people with susceptibility test result for rifampicin?
- Angola ranks 21st and Ukraine ranks 23rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.